Drawing for PRECISION FOR MEDICINE BIOSPECIMEN SOLUTIONS

USPTO serial 88578766

PRECISION FOR MEDICINE BIOSPECIMEN SOLUTIONS

Reviewed by CopyMark Law Group

Reg. 6680003Status 700Registered
Filing date
Status date
Registration date
Mar 22, 2022
Examiner
BROOKSHIRE, DAVID AARON
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PRECISION FOR MEDICINE BIOSPECIMEN SOLUTIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

DONNA H. HARTMAN

Donna H. Hartman OlenderFeldman LLP422 Morris AvenueSummit, NJ 07901UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biological tissue, namely, blood, blood plasma, blood serum, human tissues, glands and organs for use in scientific and medical researchACTIVEMay 1, 2020
039Distribution services, namely, delivery of biological tissue specimens for medical and scientific research purposes; biomedical services, namely, storage of human biological specimens, namely, blood, blood serum, tissues, glands and organs for scientific and medical research use; shipping and packing of biological specimens; storage of human biological specimens for use in medical research, development and clinical trials conducted by companies in the in-vitro diagnostics, pharmaceutical and biotechnology industriesACTIVEMay 1, 2020
042Operating and maintaining a biorepository for medical and scientific research purposes; medical and scientific laboratory services, namely, analysis and characterization of biological tissue samples; clinical trial management services for the in-vitro diagnostics, pharmaceutical and biotechnology industries, namely, the collection and handling of human biological specimens for use in medical research, development and clinical trials conducted by companies in the in-vitro diagnostics, pharmaceutical and biotechnology industriesACTIVEAug 1, 2019
044Tissue bank services; medical consulting services in the fields of surgery and pathologyACTIVEAug 1, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 22, 2022EXPTEXPARTE APPEAL TERMINATED—
Mar 22, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 12, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 11, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 20, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 20, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 13, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 13, 2022EXPIEX PARTE APPEAL-INSTITUTED—
Jan 13, 2022JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jan 13, 2022EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Jul 13, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 13, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 13, 2021CNFRSU - FINAL REFUSAL - WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 14, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 14, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 11, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 11, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 11, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 11, 2021CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2021CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 8, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 8, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 18, 2021IUAFUSE AMENDMENT FILED—
Feb 18, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 4, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 4, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jan 4, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 4, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 18, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 23, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 23, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 18, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 8, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 8, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 8, 2020ALIEASSIGNED TO LIE—
May 5, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 5, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 26, 2019DOCKASSIGNED TO EXAMINER—
Aug 29, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 17, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance